2023-2028 Global and Regional Human Oral Vaccine Industry Status and Prospects Professional Market Research Report Standard Version

Table of Contents

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2028)

1.4.2 East Asia Market States and Outlook (2023-2028)

1.4.3 Europe Market States and Outlook (2023-2028)

1.4.4 South Asia Market States and Outlook (2023-2028)

1.4.5 Southeast Asia Market States and Outlook (2023-2028)

1.4.6 Middle East Market States and Outlook (2023-2028)

1.4.7 Africa Market States and Outlook (2023-2028)

1.4.8 Oceania Market States and Outlook (2023-2028)

1.4.9 South America Market States and Outlook (2023-2028)

1.5 Global Human Oral Vaccine Market Size Analysis from 2023 to 2028

1.5.1 Global Human Oral Vaccine Market Size Analysis from 2023 to 2028 by Consumption Volume

1.5.2 Global Human Oral Vaccine Market Size Analysis from 2023 to 2028 by Value

1.5.3 Global Human Oral Vaccine Price Trends Analysis from 2023 to 2028

1.6 COVID-19 Outbreak: Human Oral Vaccine Industry Impact

Chapter 2 Global Human Oral Vaccine Competition by Types, Applications, and Top Regions and Countries

2.1 Global Human Oral Vaccine (Volume and Value) by Type

2.1.1 Global Human Oral Vaccine Consumption and Market Share by Type (2017-2022)

2.1.2 Global Human Oral Vaccine Revenue and Market Share by Type (2017-2022)

2.2 Global Human Oral Vaccine (Volume and Value) by Application

2.2.1 Global Human Oral Vaccine Consumption and Market Share by Application (2017-2022)

2.2.2 Global Human Oral Vaccine Revenue and Market Share by Application (2017-2022)

2.3 Global Human Oral Vaccine (Volume and Value) by Regions

2.3.1 Global Human Oral Vaccine Consumption and Market Share by Regions (2017-2022)

2.3.2 Global Human Oral Vaccine Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Human Oral Vaccine Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global Human Oral Vaccine Consumption by Regions (2017-2022)

4.2 North America Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.4 Europe Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.8 Africa Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

4.10 South America Human Oral Vaccine Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America Human Oral Vaccine Market Analysis

5.1 North America Human Oral Vaccine Consumption and Value Analysis

5.1.1 North America Human Oral Vaccine Market Under COVID-19

5.2 North America Human Oral Vaccine Consumption Volume by Types

5.3 North America Human Oral Vaccine Consumption Structure by Application

5.4 North America Human Oral Vaccine Consumption by Top Countries

5.4.1 United States Human Oral Vaccine Consumption Volume from 2017 to 2022

5.4.2 Canada Human Oral Vaccine Consumption Volume from 2017 to 2022

5.4.3 Mexico Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 6 East Asia Human Oral Vaccine Market Analysis

6.1 East Asia Human Oral Vaccine Consumption and Value Analysis

6.1.1 East Asia Human Oral Vaccine Market Under COVID-19

6.2 East Asia Human Oral Vaccine Consumption Volume by Types

6.3 East Asia Human Oral Vaccine Consumption Structure by Application

6.4 East Asia Human Oral Vaccine Consumption by Top Countries

6.4.1 China Human Oral Vaccine Consumption Volume from 2017 to 2022

6.4.2 Japan Human Oral Vaccine Consumption Volume from 2017 to 2022

6.4.3 South Korea Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 7 Europe Human Oral Vaccine Market Analysis

7.1 Europe Human Oral Vaccine Consumption and Value Analysis

7.1.1 Europe Human Oral Vaccine Market Under COVID-19

7.2 Europe Human Oral Vaccine Consumption Volume by Types

7.3 Europe Human Oral Vaccine Consumption Structure by Application

7.4 Europe Human Oral Vaccine Consumption by Top Countries

7.4.1 Germany Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.2 UK Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.3 France Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.4 Italy Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.5 Russia Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.6 Spain Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.7 Netherlands Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.8 Switzerland Human Oral Vaccine Consumption Volume from 2017 to 2022

7.4.9 Poland Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 8 South Asia Human Oral Vaccine Market Analysis

8.1 South Asia Human Oral Vaccine Consumption and Value Analysis

8.1.1 South Asia Human Oral Vaccine Market Under COVID-19

8.2 South Asia Human Oral Vaccine Consumption Volume by Types

8.3 South Asia Human Oral Vaccine Consumption Structure by Application

8.4 South Asia Human Oral Vaccine Consumption by Top Countries

8.4.1 India Human Oral Vaccine Consumption Volume from 2017 to 2022

8.4.2 Pakistan Human Oral Vaccine Consumption Volume from 2017 to 2022

8.4.3 Bangladesh Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia Human Oral Vaccine Market Analysis

9.1 Southeast Asia Human Oral Vaccine Consumption and Value Analysis

9.1.1 Southeast Asia Human Oral Vaccine Market Under COVID-19

9.2 Southeast Asia Human Oral Vaccine Consumption Volume by Types

9.3 Southeast Asia Human Oral Vaccine Consumption Structure by Application

9.4 Southeast Asia Human Oral Vaccine Consumption by Top Countries

9.4.1 Indonesia Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.2 Thailand Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.3 Singapore Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.4 Malaysia Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.5 Philippines Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.6 Vietnam Human Oral Vaccine Consumption Volume from 2017 to 2022

9.4.7 Myanmar Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 10 Middle East Human Oral Vaccine Market Analysis

10.1 Middle East Human Oral Vaccine Consumption and Value Analysis

10.1.1 Middle East Human Oral Vaccine Market Under COVID-19

10.2 Middle East Human Oral Vaccine Consumption Volume by Types

10.3 Middle East Human Oral Vaccine Consumption Structure by Application

10.4 Middle East Human Oral Vaccine Consumption by Top Countries

10.4.1 Turkey Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.3 Iran Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.5 Israel Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.6 Iraq Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.7 Qatar Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.8 Kuwait Human Oral Vaccine Consumption Volume from 2017 to 2022

10.4.9 Oman Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 11 Africa Human Oral Vaccine Market Analysis

11.1 Africa Human Oral Vaccine Consumption and Value Analysis

11.1.1 Africa Human Oral Vaccine Market Under COVID-19

11.2 Africa Human Oral Vaccine Consumption Volume by Types

11.3 Africa Human Oral Vaccine Consumption Structure by Application

11.4 Africa Human Oral Vaccine Consumption by Top Countries

11.4.1 Nigeria Human Oral Vaccine Consumption Volume from 2017 to 2022

11.4.2 South Africa Human Oral Vaccine Consumption Volume from 2017 to 2022

11.4.3 Egypt Human Oral Vaccine Consumption Volume from 2017 to 2022

11.4.4 Algeria Human Oral Vaccine Consumption Volume from 2017 to 2022

11.4.5 Morocco Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 12 Oceania Human Oral Vaccine Market Analysis

12.1 Oceania Human Oral Vaccine Consumption and Value Analysis

12.2 Oceania Human Oral Vaccine Consumption Volume by Types

12.3 Oceania Human Oral Vaccine Consumption Structure by Application

12.4 Oceania Human Oral Vaccine Consumption by Top Countries

12.4.1 Australia Human Oral Vaccine Consumption Volume from 2017 to 2022

12.4.2 New Zealand Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 13 South America Human Oral Vaccine Market Analysis

13.1 South America Human Oral Vaccine Consumption and Value Analysis

13.1.1 South America Human Oral Vaccine Market Under COVID-19

13.2 South America Human Oral Vaccine Consumption Volume by Types

13.3 South America Human Oral Vaccine Consumption Structure by Application

13.4 South America Human Oral Vaccine Consumption Volume by Major Countries

13.4.1 Brazil Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.2 Argentina Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.3 Columbia Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.4 Chile Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.5 Venezuela Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.6 Peru Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico Human Oral Vaccine Consumption Volume from 2017 to 2022

13.4.8 Ecuador Human Oral Vaccine Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in Human Oral Vaccine Business

14.1 Merck

14.1.1 Merck Company Profile

14.1.2 Merck Human Oral Vaccine Product Specification

14.1.3 Merck Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 GSK

14.2.1 GSK Company Profile

14.2.2 GSK Human Oral Vaccine Product Specification

14.2.3 GSK Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Sanofi

14.3.1 Sanofi Company Profile

14.3.2 Sanofi Human Oral Vaccine Product Specification

14.3.3 Sanofi Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 Lanzhou Institute

14.4.1 Lanzhou Institute Company Profile

14.4.2 Lanzhou Institute Human Oral Vaccine Product Specification

14.4.3 Lanzhou Institute Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Serum Institute

14.5.1 Serum Institute Company Profile

14.5.2 Serum Institute Human Oral Vaccine Product Specification

14.5.3 Serum Institute Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Valneva

14.6.1 Valneva Company Profile

14.6.2 Valneva Human Oral Vaccine Product Specification

14.6.3 Valneva Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.7 Shanghai United Cell

14.7.1 Shanghai United Cell Company Profile

14.7.2 Shanghai United Cell Human Oral Vaccine Product Specification

14.7.3 Shanghai United Cell Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.8 Bibcol

14.8.1 Bibcol Company Profile

14.8.2 Bibcol Human Oral Vaccine Product Specification

14.8.3 Bibcol Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.9 PaxVax

14.9.1 PaxVax Company Profile

14.9.2 PaxVax Human Oral Vaccine Product Specification

14.9.3 PaxVax Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.10 Vabiotech

14.10.1 Vabiotech Company Profile

14.10.2 Vabiotech Human Oral Vaccine Product Specification

14.10.3 Vabiotech Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.11 Tiantan Biological

14.11.1 Tiantan Biological Company Profile

14.11.2 Tiantan Biological Human Oral Vaccine Product Specification

14.11.3 Tiantan Biological Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.12 EuBiologics

14.12.1 EuBiologics Company Profile

14.12.2 EuBiologics Human Oral Vaccine Product Specification

14.12.3 EuBiologics Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.13 Panacea Biotec Ltd

14.13.1 Panacea Biotec Ltd Company Profile

14.13.2 Panacea Biotec Ltd Human Oral Vaccine Product Specification

14.13.3 Panacea Biotec Ltd Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.14 Bio-Med

14.14.1 Bio-Med Company Profile

14.14.2 Bio-Med Human Oral Vaccine Product Specification

14.14.3 Bio-Med Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.15 Halfkin Bio-Pharmaceuticals

14.15.1 Halfkin Bio-Pharmaceuticals Company Profile

14.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Specification

14.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global Human Oral Vaccine Market Forecast (2023-2028)

15.1 Global Human Oral Vaccine Consumption Volume, Revenue and Price Forecast (2023-2028)

15.1.1 Global Human Oral Vaccine Consumption Volume and Growth Rate Forecast (2023-2028)

15.1.2 Global Human Oral Vaccine Value and Growth Rate Forecast (2023-2028)

15.2 Global Human Oral Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)

15.2.1 Global Human Oral Vaccine Consumption Volume and Growth Rate Forecast by Regions (2023-2028)

15.2.2 Global Human Oral Vaccine Value and Growth Rate Forecast by Regions (2023-2028)

15.2.3 North America Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.4 East Asia Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.5 Europe Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.6 South Asia Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.7 Southeast Asia Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.8 Middle East Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.9 Africa Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.10 Oceania Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.11 South America Human Oral Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.3 Global Human Oral Vaccine Consumption Volume, Revenue and Price Forecast by Type (2023-2028)

15.3.1 Global Human Oral Vaccine Consumption Forecast by Type (2023-2028)

15.3.2 Global Human Oral Vaccine Revenue Forecast by Type (2023-2028)

15.3.3 Global Human Oral Vaccine Price Forecast by Type (2023-2028)

15.4 Global Human Oral Vaccine Consumption Volume Forecast by Application (2023-2028)

15.5 Human Oral Vaccine Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology